Jasper Hellweg
Stock Analyst at Argus Research
(2.07)
# 2,838
Out of 5,182 analysts
92
Total ratings
47.22%
Success rate
3.4%
Average return
Main Sectors:
Stocks Rated by Jasper Hellweg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintains: Buy | $360 → $400 | $340.18 | +17.58% | 1 | Feb 6, 2026 | |
| BAX Baxter International | Downgrades: Hold | n/a | $18.49 | - | 3 | Oct 31, 2025 | |
| ZTS Zoetis | Reiterates: Buy | $190 | $117.87 | +61.19% | 7 | Sep 9, 2025 | |
| BIIB Biogen | Downgrades: Hold | n/a | $180.67 | - | 4 | Apr 4, 2025 | |
| UTHR United Therapeutics | Maintains: Buy | $360 → $400 | $566.99 | -29.45% | 7 | Oct 31, 2024 | |
| ILMN Illumina | Upgrades: Buy | $150 | $128.52 | +16.71% | 7 | Aug 28, 2024 | |
| SNY Sanofi | Maintains: Buy | $55 → $60 | $45.90 | +30.72% | 2 | Jul 26, 2024 | |
| REGN Regeneron Pharmaceuticals | Maintains: Buy | $1,060 → $1,170 | $744.44 | +57.17% | 9 | Jun 25, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $465 → $550 | $426.01 | +29.10% | 7 | Jun 17, 2024 | |
| AZN AstraZeneca | Maintains: Buy | $80 → $85 | $187.51 | -54.67% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $41.20 | +203.40% | 1 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $140 | $48.70 | +187.47% | 4 | Sep 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $197.38 | - | 2 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $31.26 | - | 1 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $260 → $290 | $163.84 | +77.00% | 4 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $85.35 | +17.16% | 3 | Jun 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $270 → $295 | $263.43 | +11.98% | 4 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $8.03 | - | 3 | May 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $135 | $196.63 | -31.34% | 5 | Oct 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $11.49 | - | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $170.57 | - | 3 | Apr 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $241.79 | - | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $29.96 | - | 4 | Oct 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $155 | $445.77 | -65.23% | 3 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $90 | $61.27 | +46.89% | 1 | Sep 19, 2018 |
Amgen
Feb 6, 2026
Maintains: Buy
Price Target: $360 → $400
Current: $340.18
Upside: +17.58%
Baxter International
Oct 31, 2025
Downgrades: Hold
Price Target: n/a
Current: $18.49
Upside: -
Zoetis
Sep 9, 2025
Reiterates: Buy
Price Target: $190
Current: $117.87
Upside: +61.19%
Biogen
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $180.67
Upside: -
United Therapeutics
Oct 31, 2024
Maintains: Buy
Price Target: $360 → $400
Current: $566.99
Upside: -29.45%
Illumina
Aug 28, 2024
Upgrades: Buy
Price Target: $150
Current: $128.52
Upside: +16.71%
Sanofi
Jul 26, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $45.90
Upside: +30.72%
Regeneron Pharmaceuticals
Jun 25, 2024
Maintains: Buy
Price Target: $1,060 → $1,170
Current: $744.44
Upside: +57.17%
Vertex Pharmaceuticals
Jun 17, 2024
Maintains: Buy
Price Target: $465 → $550
Current: $426.01
Upside: +29.10%
AstraZeneca
May 30, 2024
Maintains: Buy
Price Target: $80 → $85
Current: $187.51
Upside: -54.67%
Feb 1, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $41.20
Upside: +203.40%
Sep 13, 2023
Maintains: Buy
Price Target: $160 → $140
Current: $48.70
Upside: +187.47%
Apr 5, 2023
Downgrades: Hold
Price Target: n/a
Current: $197.38
Upside: -
Jan 27, 2022
Downgrades: Hold
Price Target: n/a
Current: $31.26
Upside: -
Sep 10, 2021
Maintains: Buy
Price Target: $260 → $290
Current: $163.84
Upside: +77.00%
Jun 9, 2021
Upgrades: Buy
Price Target: $100
Current: $85.35
Upside: +17.16%
May 20, 2021
Maintains: Buy
Price Target: $270 → $295
Current: $263.43
Upside: +11.98%
May 5, 2021
Downgrades: Hold
Price Target: n/a
Current: $8.03
Upside: -
Oct 21, 2020
Upgrades: Buy
Price Target: $135
Current: $196.63
Upside: -31.34%
Apr 17, 2020
Downgrades: Hold
Price Target: n/a
Current: $11.49
Upside: -
Apr 6, 2020
Downgrades: Hold
Price Target: n/a
Current: $170.57
Upside: -
Mar 24, 2020
Downgrades: Hold
Price Target: n/a
Current: $241.79
Upside: -
Oct 30, 2019
Downgrades: Hold
Price Target: n/a
Current: $29.96
Upside: -
Nov 6, 2018
Maintains: Buy
Price Target: $150 → $155
Current: $445.77
Upside: -65.23%
Sep 19, 2018
Maintains: Buy
Price Target: $85 → $90
Current: $61.27
Upside: +46.89%